Ming Zhao

14PUBLICATIONS
16CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 22, 2025
TACE-HAIC versus TACE as Initial Regional Therapy for Unresectable Huge Hepatocellular Carcinoma (>10 cm): A Propensity Score-Matched Study.

Chong Liu, Jing Li, Ming Zhao

|May 05, 2025
The Synergistic Mechanisms and Prospects of Transarterial Chemoembolization Combined with Immunotherapy for Hepatocellular Carcinoma.

Qi-Feng Chen, Song Chen, Ming Zhao

|Feb 11, 2025
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus.

Suixing Zhong, Junzhe Yi, Song Chen

|Mar 25, 2024
Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation.

Qi-Feng Chen, Song Chen, Jun-Zhe Yi

|Mar 01, 2024
Improving the Conversion Success Rate of Hepatocellular Carcinoma: Focus on the Use of Combination Therapy with a High Objective Response Rate.

Qi-Feng Chen, Song Chen, Minshan Chen

|Feb 26, 2024
Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma.

Meng He, Yongxiang Liu, Song Chen

Pageof 3

Frequent Collaborators

5 joint publications

Ning Lyu

2 joint publications

Song Chen

1 joint publications

Shao-Long Li

1 joint publications

Hai-Jing Deng